US Stock MarketDetailed Quotes

EXAS Exact Sciences

Watchlist
  • 51.250
  • -0.700-1.35%
Trading May 17 11:37 ET
9.46BMarket Cap-39122P/E (TTM)

Exact Sciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-115.39%-82.31M
169.83%156.12M
33.65%69.55M
159.52%24.36M
264.86%100.42M
78.01%-38.22M
-118.67%-223.56M
311.77%52.04M
-0.37%-40.93M
-251.02%-60.92M
Net income from continuing operations
-48.65%-110.23M
67.26%-204.15M
61.04%-49.77M
100.53%794K
51.21%-81.03M
59.02%-74.15M
-4.68%-623.51M
42.09%-127.75M
10.89%-148.76M
6.13%-166.06M
Operating gains losses
133.06%2.42M
-141.18%-14.42M
-89.30%1.26M
--0
---8.37M
-2,378.82%-7.32M
218.93%35.02M
9,170.87%11.77M
----
----
Depreciation and amortization
8.44%53.94M
4.58%206.61M
9.48%54.17M
7.59%52.25M
-2.74%50.44M
4.40%49.74M
9.54%197.56M
9.65%49.48M
5.13%48.57M
14.43%51.86M
Deferred tax
42.51%1.8M
91.98%-955K
73.54%-676K
78.42%-951K
80.55%-589K
165.95%1.26M
95.30%-11.9M
42.62%-2.56M
-4.73%-4.41M
-119.58%-3.03M
Other non cash items
11,245.76%13.15M
-264.90%-62.55M
-173.49%-5.05M
-1,410.76%-70.56M
211.81%13.17M
99.33%-118K
-108.36%-17.14M
49.84%6.87M
-45.96%5.38M
-124.99%-11.78M
Change In working capital
-90.36%-108.21M
98.70%-342K
-61.01%26.66M
-24.83%-24.57M
5,610.18%54.42M
25.21%-56.84M
-123.74%-26.38M
-27.17%68.36M
-23.30%-19.68M
-98.66%953K
-Change in receivables
-47.58%-37.54M
-171.07%-43.42M
-109.39%-3.11M
-643.77%-19.81M
-74.80%4.94M
-330.80%-25.43M
142.89%61.09M
-15.48%33.12M
88.43%-2.66M
-38.61%19.61M
-Change in inventory
81.72%-1.07M
41.88%-7.69M
252.69%5.38M
-214.80%-543K
-202.80%-6.7M
26.83%-5.83M
-43.49%-13.23M
56.63%-3.53M
108.83%473K
-313.91%-2.21M
-Change in payables and accrued expense
-1,010.96%-53.52M
258.59%82.75M
-14.62%31.67M
123.47%2.33M
503.06%53.57M
92.71%-4.82M
-130.73%-52.18M
-64.83%37.09M
-126.69%-9.93M
-130.91%-13.29M
-Change in other current assets
51.65%-6.59M
-13,730.95%-11.62M
-264.67%-7.93M
907.89%5.94M
62.98%4M
-105.80%-13.62M
---84K
--4.82M
---735K
--2.45M
-Change in other current liabilities
-33.10%-9.51M
7.29%-20.37M
120.59%647K
-82.79%-12.48M
75.23%-1.39M
-11.75%-7.14M
-31.68%-21.97M
35.23%-3.14M
-44.10%-6.83M
-41.06%-5.61M
Cash from discontinued investing activities
Operating cash flow
-115.39%-82.31M
169.83%156.12M
33.65%69.55M
159.52%24.36M
264.86%100.42M
78.01%-38.22M
-118.67%-223.56M
311.77%52.04M
-0.37%-40.93M
-251.02%-60.92M
Investing cash flow
Cash flow from continuing investing activities
-306.70%-171.44M
-32.93%49.68M
-14.80%-66.77M
-150.72%-32.97M
206.91%66.47M
82.04%82.94M
106.84%74.07M
-174.15%-58.16M
232.01%65.01M
102.73%21.66M
Net PPE purchase and sale
-28.23%-37.65M
42.09%-124.19M
52.08%-34.92M
43.57%-25.19M
45.17%-34.72M
12.68%-29.36M
-57.96%-214.46M
-22.70%-72.88M
-14.84%-44.64M
-157.59%-63.33M
Net business purchase and sale
46.38%-237K
-19.94%-68.98M
29.92%-21.98M
-25,413.13%-40.82M
76.90%-5.73M
62.29%-442K
88.89%-57.51M
64.63%-31.37M
95.50%-160K
65.69%-24.81M
Net investment purchase and sale
-218.28%-133.35M
-24.41%243.1M
-121.17%-9.86M
-61.33%32.79M
-2.20%107.43M
40.29%112.74M
186.98%321.59M
-79.48%46.58M
1,343.80%84.8M
116.55%109.84M
Net other investing changes
---205K
-101.02%-250K
--0
-99.00%250K
----
----
141.57%24.45M
0.00%-500K
--25M
99.87%-42K
Cash from discontinued investing activities
Investing cash flow
-306.70%-171.44M
-32.93%49.68M
-14.80%-66.77M
-150.72%-32.97M
206.91%66.47M
82.04%82.94M
106.84%74.07M
-174.15%-58.16M
232.01%65.01M
102.73%21.66M
Financing cash flow
Cash flow from continuing financing activities
-102.25%-3M
108.89%159.77M
-0.65%10.04M
-60.85%92K
-74.70%16.04M
4,784.68%133.6M
802.80%76.49M
182.84%10.1M
190.12%235K
375.28%63.41M
Net issuance payments of debt
--0
175.95%137.98M
--0
--0
--0
--137.98M
310.54%50M
--0
--0
--50M
Proceeds from stock option exercised by employees
-246.06%-1.41M
-1.48%31.54M
16.96%12.3M
14.45%1.08M
5.68%17.2M
-77.49%964K
-14.64%32.02M
-13.04%10.52M
-46.38%941K
9.24%16.27M
Net other financing activities
70.17%-1.59M
-76.33%-9.75M
-443.65%-2.27M
-39.52%-985K
59.62%-1.16M
-245.44%-5.34M
-4.62%-5.53M
23.35%-417K
57.83%-706K
-84.04%-2.86M
Cash from discontinued financing activities
Financing cash flow
-102.25%-3M
108.89%159.77M
-0.65%10.04M
-60.85%92K
-74.70%16.04M
4,784.68%133.6M
802.80%76.49M
182.84%10.1M
190.12%235K
375.28%63.41M
Net cash flow
Beginning cash position
151.11%609.68M
-23.11%242.79M
152.50%594.91M
182.92%604.66M
121.84%421.66M
-23.11%242.79M
-78.83%315.77M
-14.04%235.6M
-41.29%213.72M
-82.78%190.07M
Current changes in cash
-243.98%-256.75M
600.72%365.56M
222.00%12.82M
-135.03%-8.52M
657.35%182.94M
242.14%178.32M
93.79%-73.01M
-90.45%3.98M
127.03%24.31M
103.26%24.16M
Effect of exchange rate changes
-307.27%-1.14M
4,303.33%1.32M
-39.27%1.95M
49.16%-1.24M
111.57%59K
332.07%550K
30.43%30K
13,839.13%3.21M
---2.43M
---510K
End cash Position
-16.57%351.78M
151.11%609.68M
151.11%609.68M
152.50%594.91M
182.92%604.66M
121.84%421.66M
-23.11%242.79M
-23.11%242.79M
-14.04%235.6M
-41.29%213.72M
Free cash flow
-77.52%-119.96M
107.29%31.93M
266.16%34.63M
99.03%-826K
152.88%65.7M
67.41%-67.58M
-84.04%-438.02M
75.18%-20.84M
-7.43%-85.56M
-888.69%-124.24M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -115.39%-82.31M169.83%156.12M33.65%69.55M159.52%24.36M264.86%100.42M78.01%-38.22M-118.67%-223.56M311.77%52.04M-0.37%-40.93M-251.02%-60.92M
Net income from continuing operations -48.65%-110.23M67.26%-204.15M61.04%-49.77M100.53%794K51.21%-81.03M59.02%-74.15M-4.68%-623.51M42.09%-127.75M10.89%-148.76M6.13%-166.06M
Operating gains losses 133.06%2.42M-141.18%-14.42M-89.30%1.26M--0---8.37M-2,378.82%-7.32M218.93%35.02M9,170.87%11.77M--------
Depreciation and amortization 8.44%53.94M4.58%206.61M9.48%54.17M7.59%52.25M-2.74%50.44M4.40%49.74M9.54%197.56M9.65%49.48M5.13%48.57M14.43%51.86M
Deferred tax 42.51%1.8M91.98%-955K73.54%-676K78.42%-951K80.55%-589K165.95%1.26M95.30%-11.9M42.62%-2.56M-4.73%-4.41M-119.58%-3.03M
Other non cash items 11,245.76%13.15M-264.90%-62.55M-173.49%-5.05M-1,410.76%-70.56M211.81%13.17M99.33%-118K-108.36%-17.14M49.84%6.87M-45.96%5.38M-124.99%-11.78M
Change In working capital -90.36%-108.21M98.70%-342K-61.01%26.66M-24.83%-24.57M5,610.18%54.42M25.21%-56.84M-123.74%-26.38M-27.17%68.36M-23.30%-19.68M-98.66%953K
-Change in receivables -47.58%-37.54M-171.07%-43.42M-109.39%-3.11M-643.77%-19.81M-74.80%4.94M-330.80%-25.43M142.89%61.09M-15.48%33.12M88.43%-2.66M-38.61%19.61M
-Change in inventory 81.72%-1.07M41.88%-7.69M252.69%5.38M-214.80%-543K-202.80%-6.7M26.83%-5.83M-43.49%-13.23M56.63%-3.53M108.83%473K-313.91%-2.21M
-Change in payables and accrued expense -1,010.96%-53.52M258.59%82.75M-14.62%31.67M123.47%2.33M503.06%53.57M92.71%-4.82M-130.73%-52.18M-64.83%37.09M-126.69%-9.93M-130.91%-13.29M
-Change in other current assets 51.65%-6.59M-13,730.95%-11.62M-264.67%-7.93M907.89%5.94M62.98%4M-105.80%-13.62M---84K--4.82M---735K--2.45M
-Change in other current liabilities -33.10%-9.51M7.29%-20.37M120.59%647K-82.79%-12.48M75.23%-1.39M-11.75%-7.14M-31.68%-21.97M35.23%-3.14M-44.10%-6.83M-41.06%-5.61M
Cash from discontinued investing activities
Operating cash flow -115.39%-82.31M169.83%156.12M33.65%69.55M159.52%24.36M264.86%100.42M78.01%-38.22M-118.67%-223.56M311.77%52.04M-0.37%-40.93M-251.02%-60.92M
Investing cash flow
Cash flow from continuing investing activities -306.70%-171.44M-32.93%49.68M-14.80%-66.77M-150.72%-32.97M206.91%66.47M82.04%82.94M106.84%74.07M-174.15%-58.16M232.01%65.01M102.73%21.66M
Net PPE purchase and sale -28.23%-37.65M42.09%-124.19M52.08%-34.92M43.57%-25.19M45.17%-34.72M12.68%-29.36M-57.96%-214.46M-22.70%-72.88M-14.84%-44.64M-157.59%-63.33M
Net business purchase and sale 46.38%-237K-19.94%-68.98M29.92%-21.98M-25,413.13%-40.82M76.90%-5.73M62.29%-442K88.89%-57.51M64.63%-31.37M95.50%-160K65.69%-24.81M
Net investment purchase and sale -218.28%-133.35M-24.41%243.1M-121.17%-9.86M-61.33%32.79M-2.20%107.43M40.29%112.74M186.98%321.59M-79.48%46.58M1,343.80%84.8M116.55%109.84M
Net other investing changes ---205K-101.02%-250K--0-99.00%250K--------141.57%24.45M0.00%-500K--25M99.87%-42K
Cash from discontinued investing activities
Investing cash flow -306.70%-171.44M-32.93%49.68M-14.80%-66.77M-150.72%-32.97M206.91%66.47M82.04%82.94M106.84%74.07M-174.15%-58.16M232.01%65.01M102.73%21.66M
Financing cash flow
Cash flow from continuing financing activities -102.25%-3M108.89%159.77M-0.65%10.04M-60.85%92K-74.70%16.04M4,784.68%133.6M802.80%76.49M182.84%10.1M190.12%235K375.28%63.41M
Net issuance payments of debt --0175.95%137.98M--0--0--0--137.98M310.54%50M--0--0--50M
Proceeds from stock option exercised by employees -246.06%-1.41M-1.48%31.54M16.96%12.3M14.45%1.08M5.68%17.2M-77.49%964K-14.64%32.02M-13.04%10.52M-46.38%941K9.24%16.27M
Net other financing activities 70.17%-1.59M-76.33%-9.75M-443.65%-2.27M-39.52%-985K59.62%-1.16M-245.44%-5.34M-4.62%-5.53M23.35%-417K57.83%-706K-84.04%-2.86M
Cash from discontinued financing activities
Financing cash flow -102.25%-3M108.89%159.77M-0.65%10.04M-60.85%92K-74.70%16.04M4,784.68%133.6M802.80%76.49M182.84%10.1M190.12%235K375.28%63.41M
Net cash flow
Beginning cash position 151.11%609.68M-23.11%242.79M152.50%594.91M182.92%604.66M121.84%421.66M-23.11%242.79M-78.83%315.77M-14.04%235.6M-41.29%213.72M-82.78%190.07M
Current changes in cash -243.98%-256.75M600.72%365.56M222.00%12.82M-135.03%-8.52M657.35%182.94M242.14%178.32M93.79%-73.01M-90.45%3.98M127.03%24.31M103.26%24.16M
Effect of exchange rate changes -307.27%-1.14M4,303.33%1.32M-39.27%1.95M49.16%-1.24M111.57%59K332.07%550K30.43%30K13,839.13%3.21M---2.43M---510K
End cash Position -16.57%351.78M151.11%609.68M151.11%609.68M152.50%594.91M182.92%604.66M121.84%421.66M-23.11%242.79M-23.11%242.79M-14.04%235.6M-41.29%213.72M
Free cash flow -77.52%-119.96M107.29%31.93M266.16%34.63M99.03%-826K152.88%65.7M67.41%-67.58M-84.04%-438.02M75.18%-20.84M-7.43%-85.56M-888.69%-124.24M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cancer Research
Cancer Research
Intraday-0.47%